Doxylamine PCD Pharma Franchise Company
Cafoli Lifecare offers a focused Doxylamine PCD pharma franchise built around 4 tablet formulations manufactured at WHO-GMP certified facilities. This gives franchise partners a dependable anti-nausea and antihistamine line especially valued by gynaecologists and obstetricians.
What is Doxylamine?
Doxylamine is a first-generation antihistamine (ethanolamine class) with sedative and antiemetic properties. In combination with pyridoxine (vitamin B6) it is a first-line treatment for nausea and vomiting of pregnancy, and on its own it is used as a short-term sleep aid. Read more on MedlinePlus.
Therapeutic Applications
Doxylamine, typically paired with pyridoxine, is prescribed for nausea and vomiting of pregnancy (morning sickness), and is also used for the short-term relief of insomnia and allergic symptoms. Its tablet range is prescribed mainly by obstetricians, gynaecologists and general physicians.
Why Doxylamine is a High-Potential Molecule for Distributors
The doxylamine–pyridoxine combination is one of the few pregnancy-safe antiemetics with a strong evidence base, giving it near-default status in antenatal prescribing. Antenatal patients follow up regularly, generating consistent repeat demand across the pregnancy term. For distributors targeting the gynaecology segment, doxylamine is a small but sticky, high-loyalty molecule.
Why Choose Cafoli Lifecare
Cafoli Lifecare provides territory-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, complete promotional inputs and a network of 1000+ franchise partners nationwide.
References
- MedlinePlus: Doxylamine
- PubChem: Doxylamine
Our formulations of Doxylamine find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: